India, March 13 -- image credit- shutterstock Switzerland based Tenthpin Management Consultants, a global consulting leader in technology advisory for life sciences companies, has announced the launc... Read More
India, March 13 -- Researchers atNational Institute of Technology (NIT) Rourkelahave developed a process to remove pharmaceutical pollutants from wastewater. The two-stage process combines adsorption ... Read More
India, March 13 -- Noida-based startup AlphaDroid, a pioneer in AI-driven robotics, has launched its state-of-the-art solutions to transform India's healthcare sector. Designed to enhance patient expe... Read More
India, March 13 -- The Longevity India Conference 2025 - Rise for Healthy Aging, hosted at the Indian Institute of Science (IISc), Bengaluru (from March 10th to 12th) concluded its final day with impa... Read More
India, March 13 -- Telangana is set to launch a dedicated Life Sciences policy in the coming weeks, marking a significant step towards strengthening the state's leadership in the sector. The announce... Read More
India, March 13 -- The Department of Biotechnology (DBT) and the Government of Assam have signed a landmark Memorandum of Understanding (MoU) under the BioE3(Biotechnology forEconomy,Environment, andE... Read More
India, March 13 -- image credit- shutterstock Raichur-basedShilpa Medicare Limited, a leading API and formulation manufacturer, has announced that the Subject Expert Committee (SEC) of the Central Dr... Read More
India, March 13 -- image credit- shutterstock Zynext VenturesUSALLC (Zynext Ventures), the venture capital arm of Ahmedabad-based Zydus Lifesciences, has announced its investment in US-based Illexcor... Read More
India, March 12 -- Mumbai-based Glenmark Pharmaceuticals, a research-led, global pharmaceutical company, has launched Empagliflozin, a widely recognized SGLT2 inhibitor, in India. The drug has been i... Read More
India, March 12 -- image credit- shutterstock Alkem Laboratories has announced the launch of Empanorm in India, a generic version of empagliflozin, for the treatment of type-2 diabetes mellitus, chro... Read More